Literature DB >> 17546955

CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1.

L I Karpenko1, S I Bazhan, A M Eroshkin, L R Lebedev, R V Uzhachenko, N A Nekrasova, O A Plyasunova, P A Belavin, S V Seregin, N K Danilyuk, E D Danilenko, B N Zaitsev, V I Masicheva, A A Ilyichev, L S Sandakhchiev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17546955     DOI： 10.1134/s160767290702007x

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  10 in total

1.  Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1.

Authors:  S I Bazhan; P A Belavin; S V Seregin; N K Danilyuk; I N Babkina; L I Karpenko; N A Nekrasova; L R Lebedev; A P Agafonov; G M Ignat'ev; A A Il'ichev; L S Sandakhchiev
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

2.  Design of immunogens as components of a new generation of molecular vaccines.

Authors:  V B Loktev; A A Ilyichev; A M Eroshkin; L I Karpenko; A G Pokrovsky; A V Pereboev; V A Svyatchenko; G M Ignat'ev; M I Smolina; N V Melamed; C D Lebedeva; L S Sandakhchiev
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

3.  A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.

Authors:  Clarisse Lorin; Frédéric Delebecque; Valérie Labrousse; Lucie Da Silva; François Lemonnier; Michel Brahic; Frédéric Tangy
Journal:  Vaccine       Date:  2005-08-22       Impact factor: 3.641

4.  DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

Authors:  T Hanke; J Schneider; S C Gilbert; A V Hill; A McMichael
Journal:  Vaccine       Date:  1998-02       Impact factor: 3.641

5.  Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.

Authors:  Nilu Goonetilleke; Stephen Moore; Len Dally; Nicola Winstone; Inese Cebere; Abdul Mahmoud; Susana Pinheiro; Geraldine Gillespie; Denise Brown; Vanessa Loach; Joanna Roberts; Ana Guimaraes-Walker; Peter Hayes; Kelley Loughran; Carole Smith; Jan De Bont; Carl Verlinde; Danii Vooijs; Claudia Schmidt; Mark Boaz; Jill Gilmour; Pat Fast; Lucy Dorrell; Tomas Hanke; Andrew J McMichael
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.

Authors:  H Firat; S Tourdot; A Ureta-Vidal; A Scardino; A Suhrbier; F Buseyne; Y Rivìere; O Danos; M L Michel; K Kosmatopoulos; F A Lemonnier
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

7.  Design of four-helix bundle protein as a candidate for HIV vaccine.

Authors:  A M Eroshkin; E A Karginova; I P Gileva; A S Lomakin; L R Lebedev; T P Kamyinina; A V Pereboev; G M Ignat'ev
Journal:  Protein Eng       Date:  1995-02

Review 8.  A review of vaccine research and development: the human immunodeficiency virus (HIV).

Authors:  Marc P Girard; Saladin K Osmanov; Marie Paule Kieny
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

9.  Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.

Authors:  Sergei I Bazhan; Pavel A Belavin; Sergei V Seregin; Nadezhda K Danilyuk; Irina N Babkina; Larisa I Karpenko; Nadezhda A Nekrasova; Leonid R Lebedev; George M Ignatyev; Alexander P Agafonov; Vera A Poryvaeva; Irina V Aborneva; Alexander A Ilyichev
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

10.  Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen.

Authors:  Larisa I Karpenko; Nadezhda A Nekrasova; Alexander A Ilyichev; Leonid R Lebedev; George M Ignatyev; Alexander P Agafonov; Boris N Zaitsev; Pavel A Belavin; Sergei V Seregin; Nadezhda K Danilyuk; Irina N Babkina; Sergei I Bazhan
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641
  10 in total
  1 in total

1.  Investigation of disperse contents and attributes of natural biologically active agents nanoaerosols.

Authors:  M P Anisimov; V F Podgorny; V A Sokolov; P A Panikhin; A V Trilis
Journal:  Dokl Biochem Biophys       Date:  2010 May-Jun       Impact factor: 0.788
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.